ICD-10-CM Code H59.42

Inflammation (infection) of postprocedural bleb, stage 2

Version 2021 Billable Code

Valid for Submission

H59.42 is a billable code used to specify a medical diagnosis of inflammation (infection) of postprocedural bleb, stage 2. The code is valid for the fiscal year 2021 for the submission of HIPAA-covered transactions.

ICD-10:H59.42
Short Description:Inflammation (infection) of postprocedural bleb, stage 2
Long Description:Inflammation (infection) of postprocedural bleb, stage 2

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code H59.42 are found in the index:


Diagnostic Related Groups

The ICD-10 code H59.42 is grouped in the following groups for version MS-DRG V38.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2020 through 09/30/2021.

  • 124 - OTHER DISORDERS OF THE EYE WITH MCC
  • 125 - OTHER DISORDERS OF THE EYE WITHOUT MCC

Convert H59.42 to ICD-9

  • 379.62 - Inflam postproc bleb, 2

Code Classification

  • Diseases of the eye and adnexa (H00–H59)
    • Intraoperative and postprocedural complications and disorders of eye and adnexa, not elsewhere classified (H59)
      • Intraop and postproc comp and disord of eye and adnexa, NEC (H59)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021